Stocks to sell

As we race out of the global pandemic, is there still a need for the Covid-19 vaccine being developed by biopharmaceutical company Ocugen (NASDAQ:OCGN)? And what does that mean for OCGN stock? Source: Shutterstock The Malvern, Pennsylvania-based company’s share price has largely been propped up in recent months on excitement related to its proposed vaccine

Virgin Galactic (NYSE:SPCE) is going  on a very dangerous journey over the next 12 to 18 months. Amid multiple signs that SPCE stock could very well continue to crash during this trip, I continue to recommend that investors find a way to disembark from Virgin. Source: Christopher Penler / Shutterstock.com More specifically, past technical issues,

AMC Entertainment (NYSE:AMC) has become famous for its “meme stock” presence. In other words, AMC stock and others have become the go-to short-squeeze names and have become well-known favorites among Reddit traders.  Source: rblfmr/Shutterstock.com Earlier this year, we saw an incredible development. Massive short-squeezes across the board had algos, retail traders and others looking to

Turn on business news and chances are, you’ll find more pundits talking about how the craziness in the broader investment market will continue inching forward. But at some point, everybody has to at least start considering stocks to sell. Simply put, the arena is full of both bulls and bears. And the latter may be

Special purpose acquisition company (SPAC) deals that looked great in February now look very dicey. Like the effort by Churchill Capital IV (NASDAQ:CCIV) to buy electric car maker Lucid Motors and become LCID. The CCIV stock story highlights the risks in the SPAC phenomenon. Source: Dmitry Demidovich/ShutterStock.com First, you don’t know the merger target. Once

In my last write-up for Lordstown Motors (NASDAQ:RIDE) stock, I suggested that the company may be overvalued based on economic metrics. Source: Postmodern Studio / Shutterstock.com Specifically, unemployment trends for the construction industry were more negative than the national trend, which suggested that commercial fleet owners would not be willing to open their wallets. Naturally,

Excitement over its move into lidar sent MicroVision (NASDAQ:MVIS) stock parabolic back in April, but it didn’t last wrong. As the “meme stock” hype around it faded a bit, shares have fallen back to around $14 per share, down from prices above $25 per share. Source: Shutterstock With around 21.5% of its outstanding float sold

I’ll continue to be bearish regarding Sundial Growers (NASDAQ:SNDL) stock until it shows investors something positive. Recent earnings only make the situation bleaker and bleaker. Source: Shutterstock And while acquisition news seems appropriate and strategically logical, the results have yet to be seen.  The Lone Positive is False Hope Earnings releases should always be taken

Buying Luminar Technologies (NASDAQ:LAZR) stock is a bet that Light Detection and Ranging  (Lidar) will become the standard for making vehicles safe and even autonomous. Source: JHVEPhoto/shutterstock.com It’s also a bet on 26-year old Austin Russell, a California native who took Luminar public in December through a SPAC called Gores Metropoulos. LAZR stock shot out

The disruption that the novel coronavirus caused last year was nothing like we’ve had in centuries. Luckily, we have amazing vaccine companies that succeeded, plus others like Novavax (NASDAQ:NVAX) trying their hardest. NVAX stock is still full of potential and today we will debate owning it. Source: Ascannio/Shutterstock.com Pfizer (NYSE:PFE), Moderna (NASDAQ:MRNA) and AstraZeneca (NASDAQ:AZN)

After reviewing the statements of experts on the state of the pandemic in the U.S., reading CDC projections on the course that the coronavirus is likely to take and analyzing Ocugen’s (NASDAQ:OCGN) recent first-quarter earnings conference call, I remain extremely bearish on OCGN stock. Source: Shutterstock.com Ocugen has said that it is trying to get

It’s abundantly clear that the Reddit-driven rallies in names like Sundial Growers (NASDAQ:SNDL) stock went too far. The supposedly epic “short squeezes” promised since late January haven’t materialized. GameStop (NYSE:GME), AMC Entertainment (NYSE:AMC), SNDL stock and others remain well off their peaks. There’s plenty of reason for skepticism toward those names going forward as well.

In this crazy market environment where bearishness equates to a reason to buy a particular equity unit, it should be no surprise in this context that Zomedica (NYSEAMERICAN:ZOM) previously dominated the charts. Given that ZOM stock once closed near the $3 level, shares at less than 80 cents sounds like a reasonable opportunity. But if

Vaxart (NASDAQ:VXRT) tried to produce a Covid-19 vaccine that could be taken orally as a pill, but it failed. As a result, VXRT stock is probably headed down 85% to its cash per share level, or about $1.00. Source: Ascannio / Shutterstock.com This is nothing new. Most investors will remember the stock’s collapse back in

While no one knows for sure what the recent rumblings in the major indices entails, looking at the bigger picture, the post-novel-coronavirus rally has been one of the most remarkable in history. Naturally, the bullishness extended to high-profitability potential growth investments like Senseonics (NYSEAMERICAN:SENS). As a play on the science, Senseonics is brilliant. As a

Quantumscape (NYSE:QS), the lithium-metal solid-state battery company, has a funding hole over the next four years. This could easily drag QS stock down further, despite its miserable performance so far. Source: Michael Vi / Shutterstock.com That is a depressing prospect for shareholders who have seen the stock deteriorate. It is down 68% year-to-date, and even

The pandemic hasn’t been easy for anyone, but it has been the toughest for AMC Entertainment (NYSE:AMC). The theatre chain has faced several problems over the past year, and after being a target of Reddit’s short squeeze, AMC stock has consistently been volatile.  Source: Helen89 / Shutterstock.com The stock went from $2 to hit a

Gevo (NASDAQ:GEVO), the Colorado-based renewable jet fuel producer, has $530.6 million in cash, but its market cap is now about $1.048 billion. This means cash is now 50% of its market value or $2.66 per share. Wait for GEVO stock to drop closer to the cash per share, despite the value of its much-touted patents.

It could be said that movie-theater chain AMC Entertainment (NYSE:AMC) stock is the ultimate beneficiary of the recovery from the Covid-19 pandemic. Or at least, that’s what some AMC stockholders are hoping for. Source: Helen89 / Shutterstock.com Granted, AMC has reopened nearly all of its theaters in North America. Moreover, the company is gradually bringing moviegoers

Palantir (NYSE:PLTR) stock may be starting to get out of its slump. Since February, the big data play, and Reddit favorite, has slid significantly from its highs. But, thanks to a strong earnings report, and a possible investment of company funds into Bitcoin (CCC:BTC-USD), shares have bounced back, after briefly falling below the $20 per